Home > List of Issue > Table of Contents > Abstract

Journal of Nippon Medical School

Full Text of this Article

-Original-

Factors Associated with High-sensitivity Cardiac Troponin T in Patients with Type 2 Diabetes Mellitus

Takashi Hitsumoto

Hitsumoto Medical Clinic


Background: The blood concentration of high-sensitivity cardiac troponin T (hs-cTnT) is an established, useful biomarker for evaluating the pathogenesis of heart failure and predicting cardiovascular events. The aim of this study was to evaluate factors that are potentially associated with elevated blood hs-cTnT in patients with type 2 diabetes mellitus.
Patients and Methods: Patients with type 2 diabetes mellitus (N=280, 111 men and 169 women; mean ± SD age: 71±9 years) with no history of cardiovascular events were enrolled. Relationships between hs-cTnT level and various clinical parameters were examined.
Results: Hs-cTnT was detected in 244 (87.1%) patients. There were no significant relationships between hs-cTnT and fasting blood glucose levels or insulin resistance. hs-cTnT was significantly correlated with advanced glycation end-product levels at the skin (r=0.23, p<0.001), blood concentrations of brain natriuretic peptide (r=0.23, p<0.001), reactive oxygen metabolites as markers of oxidative stress (r=0.28, p<0.001), and the augmentation index at the radial artery as marker of arterial reflection (r=0.31, p<0.001). Furthermore, multiple regression analysis revealed that these factors were also selected as independent variables, with hs-cTnT as a subordinate factor.
Conclusion: These results indicate that novel cardiovascular risk factors including advanced glycation end-products, in vivo oxidative stress, and high arterial reflection are closely associated with high concentrations of blood hs-cTnT in patients with type 2 diabetes mellitus.

J Nippon Med Sch 2015; 82: 274-280

Keywords
troponin, type 2 diabetes mellitus, advanced glycation end products, oxidative stress, augmentation index

Correspondence to
Takashi Hitsumoto, MD, Hitsumoto Medical Clinic, 2-7-7 Takezakicyo, Shimonoseki City, Yamaguchi 750-0025, Japan
web@hitsumoto.info

Received, July 7, 2015
Accepted, October 29, 2015